Beta Health Weight Management Center and Medi Spa

Beta Health Weight Management Center and Medi Spa's peptide therapy menu includes Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.

The weight management programs at Beta Health center on GLP-1 receptor agonist therapy using semaglutide and tirzepatide, both FDA-approved medications that regulate appetite and glucose metabolism. These peptides are administered through individualized dosing schedules determined by patient response, metabolic markers, and weight loss goals. BPC-157, a synthetic peptide derived from gastric protective protein, is offered for patients experiencing joint discomfort, soft tissue injuries, or gut health concerns that may accompany lifestyle modification. NAD+ infusions support mitochondrial function and energy production during caloric restriction phases, while GHK-Cu peptide therapy addresses skin laxity and collagen synthesis as body composition changes. Each peptide serves a distinct physiological function within the broader treatment plan, rather than operating as standalone interventions.

The nurse practitioner-led clinical team at Beta Health conducts comprehensive intake assessments that include metabolic panel analysis, body composition measurement, and health history review before initiating peptide therapy. Treatment plans are tailored based on individual metabolic profiles, existing health conditions, and specific aesthetic or functional goals. Patients receive ongoing monitoring through follow-up appointments that track weight trends, side effect profiles, and treatment response markers. The Owings Mills location provides both in-office peptide administration and at-home injection training for patients who prefer self-administration between clinical visits. Hormone therapy services complement weight management protocols for patients whose metabolic challenges relate to thyroid dysfunction, sex hormone imbalances, or age-related hormonal decline.

Patients at Beta Health typically begin with an initial consultation that establishes baseline metrics and determines peptide candidacy based on contraindications, medication interactions, and treatment objectives. Semaglutide and tirzepatide programs generally involve weekly subcutaneous injections with dose titration over 12-16 weeks, while BPC-157 and GHK-Cu may be administered through injection or topical application depending on treatment goals. NAD+ therapy is delivered via intravenous infusion in the medi spa setting, with session durations ranging from 90 minutes to several hours based on dosage. The clinic environment accommodates both medical weight loss consultations and aesthetic treatment sessions, allowing patients to address multiple health objectives during single visits. IV therapy suites provide a dedicated space for NAD+ infusions and other intravenous nutrient protocols that support metabolic function during active weight loss phases.

Beta Health Weight Management Center distinguishes itself through the integration of medical weight loss and regenerative peptide therapy within a medi spa environment, eliminating the need for patients to coordinate care across multiple providers or locations. The Owings Mills facility serves patients throughout Baltimore County and surrounding Maryland communities, offering appointment scheduling that accommodates working professionals. The nurse practitioner model ensures clinical oversight while maintaining accessibility and personalized attention throughout treatment courses. Patients pursuing long-term weight maintenance can transition from active weight loss protocols to maintenance peptide dosing and aesthetic treatments that address body contouring, skin quality, and age management as their health goals evolve beyond initial weight reduction targets.